Abstract:A tumor is a severe threat to human life and health. Tumor markers are usually found in tissues, serum, and other body fluids. These markers reflect tumor occurrence and are closely associated with their diagnosis, treatment, and monitoring. Tumor marker detection is an effective method for early tumor screening. Early tumor screening can save patients time and is the key to tumor prevention and treatment. With the advancement of precision medicine, tumor marker detection technology requirements are constantly increasing, and it is of great significance to develop a convenient, sensitive and accurate method for detecting tumor markers. Utilizing localized surface plasmon resonance (LSPR) among nanoparticles enhances the spectral signals of molecules, thereby improving detection sensitivity and accuracy, surface-enhanced Raman spectroscopy (SERS) technology is a powerful tool and a hot spot in tumor marker detection research with potential in biomedicine, clinical diagnosis, and other fields. The current paper reviews the research progress of SERS in the field of tumor marker tissue detection and liquid biopsy in the past five years. Moreover, the study proposes new ideas to improve the sensitivity of biomarker detection with sample processing, base improvement, and probe research. (1) Using specific adsorption materials and membrane separation technology to optimize the sample and reduce the influence of sample matrix in SERS detection. (2) Absorbing targeted marker molecules with specific probes of antibodies and DNA aptamer to improve the detection specificity and reduce the excessive diagnosis cases due to high sensitivity. (3) Researching the structure, measurement, and size of metal nanoparticles of the base to generate more spots and improve sensitivity. (4) Incorporating other fields like electrochemistry to make up for the SERS detection defect. Meanwhile, we analyzed and prospected the challenges and development of SERS technology in clinical application. Attention should be paid to the stability and biocompatibility of SERS labels, substrate reproducibility, and cost. In practical application, it is necessary to consider the cost-benefit, service cycle, and ease of handling of SERS substrate. Therefore, the research scholar should continue identifying materials that can replace gold, silver, and other nanoparticles. Moreover, a renewable substrate can be prepared to reduce the cost and enhance the stability of the experimental results. SERS technology has a short exploration time in the clinical application stage and requires significant clinical verification and promotion. In the future, predicting potential tumor markers and detecting multiple tumor markers combined with applying the advantages of SERS technology could provide high sensitivity and accuracy. Meanwhile, producing portable sensors for POCT may become a research trend. Thus, it will also provide clinical significance for detecting tumor markers. Sensors developed by SERS technology are of great significance for clinical tumor marker detection. The abovementioned factors can be fully considered and overcome when developing new detection technologies. In that case, the developed sensors will be more widely used for clinical diagnosis, food safety, and environmental protection, among other fields.

PD-L1 Targeted Iron Oxide SERS Bioprobe for Accurately Detecting Circulating Tumor Cells and Delineating Tumor Boundary

Ultrahigh SERS activity of the TiO2@Ag nanostructure leveraged for accurately detecting CTCs in peripheral blood

Gold nanorods with iron oxide dual-modal bioprobes in SERS-MRI enable accurate programmed cell death ligand-1 expression detection in triple-negative breast cancer

A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells

TiO2-based Surface-Enhanced Raman Scattering bio-probe for efficient circulating tumor cell detection on microfilter

TiO2-Based Bioprobe Enabling Excellent SERS Activity in Detection of Diverse Circulating Tumor Cells

A TiO2-based Bioprobe Enabling Excellent SERS Activity in the Detection of Diverse Circulating Tumor Cells.

Octahedral Silver Oxide Nanoparticles Enabling Remarkable SERS Activity for Detecting Circulating Tumor Cells

An efficient strategy for circulating tumor cell detection: surface-enhanced Raman spectroscopy

Precise diagnosis of tumor cells and hemocytes using ultrasensitive, stable, selective cuprous oxide composite SERS bioprobes assisted with high-efficiency separation microfluidic chips

Efficient Detection of Single Circulating Tumor Cell in Blood Using Raman Mapping Based on Aptamer-SERS Bio-Probe Coupled with Micropore Membrane Filtration.

Improved SERS Nanoparticles for Direct Detection of Circulating Tumor Cells in the Blood.

A rapid and simple method for efficient capture and accurate discrimination of circulating tumor cells using aptamer conjugated magnetic beads and surface-enhanced Raman scattering imaging

Machine Learning Assisted Dual-Modal SERS Detection for Circulating Tumor Cells

Trace Analysis of Multiple Tumor Exosomal PD‐L1 Based on SERS Immunoassay Platform

Detection of Circulating Tumor Cells Based on Improved SERS-active Magnetic Nanoparticles

Advances in Surface‐enhanced Raman Scattering Bioprobes for Cancer Imaging

Beehive-Inspired Macroporous SERS Probe for Cancer Detection through Capturing and Analyzing Exosomes in Plasma

Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA

Advances in Tumor Marker Detection Using Surface-Enhanced Raman Spectroscopy

A novel ternary heterostructure with dramatic SERS activity for evaluation of PD-L1 expression at the single-cell level.